These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8210704)

  • 1. l-5-formyltetrahydrofolate and l-5-methyltetrahydrofolate rescue in L1210 leukemia treated with high methotrexate doses.
    Simile MM; DeMiglio MR; Nufris A; Pascale RM; Muroni MR; Feo F
    Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):251-4. PubMed ID: 8210704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identical efficacy of methotrexate regimens with N5-methyltetrahydrofolate rescue or with leucovorin rescue for treatment of L1210 murine leukemia.
    Nixon PF; Wilson L
    Cancer Treat Rep; 1983 Jan; 67(1):59-62. PubMed ID: 6604578
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
    Sirotnak FM; Moccio DM; Dorick DM
    Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate rescue by 5-methyltetrahydrofolate or 5-formyltetrahydrofolate in lymphoblast cell lines.
    Dudman NP; Slowiaczek P; Tattersall MH
    Cancer Res; 1982 Feb; 42(2):502-7. PubMed ID: 6976826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
    Zhao R; Gao F; Goldman ID
    Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL; Straw JA
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of the reversal of methotrexate toxicity in rodents.
    Kisliuk RL; Tattersall MH; Gaumont Y; Pastore EJ; Brown B
    Cancer Treat Rep; 1977 Jul; 61(4):647-50. PubMed ID: 301779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of methotrexate with 5-methyltetrahydrofolate rescue and dietary homocystine on survival of leukemic mice and on concentrations of liver adenosylamino acids.
    Hilton MA; Hoffman JL; Sparks MK
    Cancer Res; 1983 Nov; 43(11):5210-6. PubMed ID: 6616457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
    Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated mice.
    Bunni MA; Sirotnak FM; Otter GM; Priest DG
    Cancer Chemother Pharmacol; 1994; 34(6):455-8. PubMed ID: 7923554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approach to antifolate treatment of certain cancers as demonstrated in tissue culture.
    Halpern RM; Halpern BC; Clark BR; Ashe H; Hardy DN; Jenkinson PY; Chou SC; Smith RA
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4018-22. PubMed ID: 1081693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartment.
    Chu BC; Howell SB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):389-93. PubMed ID: 6974776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
    Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
    Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P; Cerna I
    Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo.
    Sirotnak FM; Goutas LJ; Mines LS
    Cancer Res; 1985 Oct; 45(10):4732-4. PubMed ID: 3875399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
    Zhao R; Gao F; Babani S; Goldman ID
    Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.
    Matherly LH; Czajkowski CA; Muench SP; Psiakis JT
    Cancer Res; 1990 Jun; 50(11):3262-9. PubMed ID: 2139802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors.
    Ferguson K; Boschelli D; Hoffman P; Oronsky A; Whiteley J; Webber S; Galivan J; Freishiem J; Hynes J; Kerwar SS
    Cancer Chemother Pharmacol; 1989; 25(3):173-6. PubMed ID: 2598407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.